This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Alstonia scholaris, commonly known as Dita bark or devil's tree, is a medicinal plant used in traditional Asian medicine for respiratory, metabolic, and inflammatory conditions [PMID:24486598, PMID:20702494].
Background
Alstonia scholaris (L.) R. Br. is an evergreen tropical tree of the Apocynaceae family native to South and Southeast Asia [PMID:24486598, PMID:24390624, PMID:32583785].
Traditional uses
In India, it is used to treat malaria, jaundice, gastrointestinal troubles, and cancer [PMID:24486598]. In China's 'Dai' ethno-medicine system, it is used for respiratory diseases (cough, asthma, phlegm, COPD), gouty arthritis, and 'water related diseases' such as chronic kidney disease [PMID:24486598, PMID:35150817, PMID:37453192, PMID:26707569]. It is also used in Papua Island, Indonesia, as an antimalarial treatment [PMID:37176870].
Active compounds
The plant contains monoterpenoid indole alkaloids (MIAs) including vallesamine, scholaricine, 19-epischolaricine, and picrinine [PMID:32387234, PMID:38646178]. Other identified compounds include triterpenoids (betulinic acid, oleanolic acid, ursolic acid, and lupanes), flavonoids, and isoflavonoids [PMID:35150817, PMID:24390624, PMID:37857337, PMID:31227424, PMID:38453990].
Mechanism of action
Alstonia scholaris may ameliorate diabetic nephropathy through the PPAR-δ pathway [PMID:40294665]. Its indole alkaloids have demonstrated anti-inflammatory effects by downregulating proteins such as NLRP3, TLR4, NF-κB, and p38 in hepatocyte cells [PMID:37981062]. In pulmonary fibrosis, it reduces TGF-β, hydroxyproline, and type I collagen while enhancing superoxide dismutase activity [PMID:33148433].
Clinical evidence
Evidence DRespiratory Infections/Diseases
Total alkaloids from leaves inhibited HSV-1, RSV, and H1N1 in vitro and prolonged survival in H1N1 and beta-hemolytic streptococcus mice models [PMID:33389714]. It also showed anti-pulmonary fibrosis effects [PMID:33148433] and protected against emphysema in mice [PMID:32387234].
Evidence DHyperuricemia/Gout
Non-alkaloids fractions and specific lupanes significantly reduced serum uric acid levels in mice [PMID:35150817, PMID:37857337].
Evidence DDiabetic Nephropathy
Four major alkaloids mitigated high glucose-induced renal podocyte injury and restored oxidation balance [PMID:40294665].
Evidence DHypertension
The n-butanol fraction demonstrated vasorelaxant effects on rat aorta [PMID:26429073].
Evidence DCancer
Preclinical studies with neoplastic cells and tumor-bearing animals validated antineoplastic effects of phytochemicals like echitamine and lupeol [PMID:20702494].
Evidence D
Safety & adverse effects
Some indole alkaloids, including scholaricine, 19-epischolaricine, vallesamine, and picrinine, have demonstrated toxic effects in non-rodent models [PMID:34325978]. Additionally, A. scholaris pollen is identified as an allergen, causing positive skin reactions in 28.57% of tested respiratory allergic patients [PMID:23963866].
Evidence summary
The current evidence is primarily based on in vitro studies and animal models (Level D), with some supportive review articles (Level C). There is a lack of human clinical trial data in the provided abstracts.
PubMed sources
1.PMID: 24486598 (2014) — Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology. · Journal of ethnopharmacology
2.PMID: 40294665 (2025) — Alstonia scholaris (L.) R. Br. ameliorated diabetic nephropathy through PPAR-δ pathway. · Journal of ethnopharmacology
3.PMID: 35150817 (2022) — Anti-hyperuricemic bioactivity of Alstonia scholaris and its bioactive triterpenoids in vivo and in vitro. · Journal of ethnopharmacology
4.PMID: 33152933 (2020) — Pharmacological insights and prediction of lead bioactive isolates of Dita bark through experimental and computer-aided mechanism. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
In a Syrian hamster model, A. scholaris showed robust anti-viral and immunomodulatory potential [PMID:37765142].
(2020)
— Phytochemical screening of Alstonia scholaris leaf and bark extracts and their antimicrobial activities.
· Cellular and molecular biology (Noisy-le-Grand, France)
6.PMID: 37453192 (2023) — Pharmacological investigation of indole alkaloids from Alstonia scholaris against chronic glomerulonephritis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
7.PMID: 29130799 (2017) — Allergen immunotherapy modulates sensitivity of Treg cells to apoptosis in a rat model of allergic asthma. · Immunotherapy
8.PMID: 37857337 (2023) — New Lupanes from Alstonia scholaris Reducing Uric Acid Level. · Planta medica
9.PMID: 26429073 (2015) — Mechanisms underlying the antihypertensive effect of Alstonia scholaris. · Journal of ethnopharmacology
10.PMID: 33389714 (2021) — Anti-microbial Effects In Vitro and In Vivo of Alstonia scholaris. · Natural products and bioprospecting
11.PMID: 33148433 (2021) — Pharmacological effects of indole alkaloids from Alstonia scholaris (L.) R. Br. on pulmonary fibrosis in vivo. · Journal of ethnopharmacology
13.PMID: 38266954 (2024) — Monoterpenoid indole alkaloids from Alstonia scholaris and their Toxoplasma gondii inhibitory activity. · Phytochemistry
14.PMID: 30319940 (2018) — Ameliorating effect of Alstonia scholaris L. bark extract on histopathological changes following viper envenomation in animal models. · Toxicology reports
15.PMID: 37176870 (2023) — Potential Plant-Based New Antiplasmodial Agent Used in Papua Island, Indonesia. · Plants (Basel, Switzerland)
16.PMID: 24390624 (2014) — The role of pentacyclic triterpenoids in the allelopathic effects of Alstonia scholaris. · Journal of chemical ecology
17.PMID: 38453990 (2024) — Biosynthesis of copper nanoparticles using Alstonia scholaris leaves and its antimicrobial studies. · Scientific reports
18.PMID: 20381600 (2010) — Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities. · Journal of ethnopharmacology
19.PMID: 33996502 (2021) — Synthesis, characterization & evaluation of venom neutralization potential of silver nanoparticles mediated Alstonia scholaris Linn bark extract. · Toxicology reports
20.PMID: 26707569 (2016) — Effect of total alkaloids from Alstonia scholaris on airway inflammation in rats. · Journal of ethnopharmacology
21.PMID: 37765142 (2023) — Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris. · Pharmaceuticals (Basel, Switzerland)
22.PMID: 20702494 (2010) — Alstonia scholaris Linn R Br in the treatment and prevention of cancer: past, present, and future. · Integrative cancer therapies
23.PMID: 31227424 (2019) — Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. · Journal of integrative medicine
24.PMID: 23963866 (2014) — Aerobiological, clinical, and immunobiochemical studies on Alstonia scholaris pollen from Eastern India. · Environmental monitoring and assessment
25.PMID: 34325978 (2021) — Therapeutic potential of indole alkaloids in respiratory diseases: A comprehensive review. · Phytomedicine : international journal of phytotherapy and phytopharmacology
26.PMID: 32387234 (2020) — Indole alkaloids from leaves of Alstonia scholaris (L.) R. Br. protect against emphysema in mice. · Journal of ethnopharmacology
27.PMID: 38646178 (2024) — Chromosome-level Alstonia scholaris genome unveils evolutionary insights into biosynthesis of monoterpenoid indole alkaloids. · iScience